Surging patient interest in self-managed healthcare delivery models has propelled Digital Therapeutics (DTx) to the forefront of medicine. With an aim to deliver on-demand, personalized and patient-centric care, the healthcare ecosystem is actively integrating DTx across its existing patient care infrastructure.
Zinnov, a leading global management and strategy consulting firm in partnership with HARMAN, a global leader in connected solutions, is hosting an exclusive Virtual Roundtable Discussion on the theme “Digital Therapeutics – Opportunities and Challenges” on 22th April 2021 from 8:00 AM to 9:30 AM PDT / 10:00 AM to 11:30 AM CDT / 11:00 AM to 12:30 PM EDT.
Healthcare stakeholders are increasingly deploying investments towards technologies such as AR/VR, AI/ML, sensors, platforms, etc., and are focusing on developing relevant digital capabilities to build DTx solutions. By providing access to real-world patient data for improved drug efficacy & individualized therapy, better patient engagement, and reduced cost of care, DTx is uniquely positioned to provide meaningful benefits across the spectrum of healthcare stakeholders.
A key factor propelling the adoption of DTx is Partnerships. Join us as we bring together the entire healthcare ecosystem of Providers, Medical Device Manufacturers, Pharmaceuticals and health-tech companies onto the same platform to discuss the evolving use-cases for digital therapeutics along with the implementation and scaling challenges.